Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · IEX Real-Time Price · USD
2.830
-0.220 (-7.21%)
At close: Jul 19, 2024, 4:00 PM
2.840
+0.010 (0.35%)
Pre-market: Jul 22, 2024, 7:37 AM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $590.86 million as of July 22, 2024. Its market cap has decreased by -19.29% in one year.
Market Cap
590.86M
Enterprise Value
195.71M
1-Year Change
-19.29%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.84B to $590.86M, a decrease of -79.21%. That is a compound annual growth rate of -23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 483.50M | -10.50% |
| Dec 29, 2023 | 540.20M | -40.45% |
| Dec 30, 2022 | 907.10M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | 3.54B | 11.80% |
| Dec 31, 2019 | 3.17B | -3.19% |
| Dec 31, 2018 | 3.27B | 15.10% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZimVie | 595.44M |
| Adaptive Biotechnologies | 595.37M |
| Larimar Therapeutics | 594.63M |
| Surmodics | 594.30M |
| Annexon | 593.48M |
| Applied Therapeutics | 587.33M |
| Emergent BioSolutions | 586.90M |
| Varex Imaging | 580.78M |